Correction: Ketamine for depression – evidence and proposals for practice

Kvam, Tor-Morten; Stewart, Lowan H.; Blomkvist, Andreas Wahl; Andreassen, Ole A.

doi:10.4045/tidsskr.21.0760

Cited by 3 publications

(3 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Figures like Jean-Martin Charcot and Sigmund Freud, although making enormous contributions to the comprehension of the nervous system and the mind, unintentionally promoted the division between neurological and psychiatric illnesses. Charcot's emphasis on discovering the organic origins of mental diseases resulted in progress in the field of neurology [4]. However, Freud's psychoanalytic theories highlighted psychological elements, paving the way for a distinct path in psychiatry.…”

Section: Historical Overviewmentioning

confidence: 99%

“…The impact of prominent individuals during this period, such as Jean-Martin Charcot and Sigmund Freud, was crucial in establishing clear distinctions between neurology and psychiatry. Charcot's pioneering research in neurology showed the basis for comprehending conditions with distinct physical associations [4]. In contrast, Freud's psychoanalytic theories directed psychiatry toward investigating the subconscious mind and psychodynamic mechanisms.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Neuropsychiatric Disorders: Bridging the Gap Between Neurology and Psychiatry

Taslim,

Shadmani,

Saleem

et al. 2024

Cureus

View full text Add to dashboard Cite

Given the ongoing difficulties faced by clinicians and researchers in dealing with neuropsychiatric illnesses, it is becoming more and more evident that there is a need to go beyond traditional disciplinary boundaries. This research consolidates existing material, examining changes in history, the fundamental neurobiological aspects, and the shared clinical manifestations between neurology and psychiatry. This inquiry examines the historical development of neuropsychiatry, focusing on the relationship between early understandings of mental illness and the later division of neurology and psychiatry. The focus is on recent advancements in comprehending the common neurobiological pathways and genetic factors that highlight the merging of these fields. The research highlights the complexities of clinical presentations in neuropsychiatric illnesses by analyzing the overlapping cognitive, affective, and behavioral symptoms. The text critiques the diagnostic issues in traditional frameworks, emphasizing the limitations in differentiating between neurological and psychiatric origins. This has ramifications for achieving correct diagnosis and arranging appropriate treatment. The paper explores developing multidisciplinary care approaches, highlighting successful collaborations between neurologists and psychiatrists. This study examines the difficulties in carrying out a plan and the process of identifying obstacles to combining different elements. It also highlights the urgent need for improved instruction and learning for smooth cooperation. The paper examines the therapeutic implications by investigating pharmacological therapies focusing on shared pathways. It also discusses the difficulties involved in managing neurological and psychiatric diseases that occur together. The study also explores non-pharmacological therapies, such as psychotherapy and rehabilitation methods, as part of a comprehensive treatment approach. Anticipating the future, the report identifies areas where the study could be improved and forecasts the influence of technological improvements on the subject. Suggestions are put out to encourage additional exploration, cooperation, and originality to narrow the divide between neurology and psychiatry, ultimately augmenting our comprehension and treatment of neuropsychiatric illnesses. This real-time synthesis adds to the ongoing discussion, providing valuable insights that align with the ever-changing field of contemporary neuropsychiatric research and therapy.

show abstract

Section: Historical Overviewmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Neuropsychiatric Disorders: Bridging the Gap Between Neurology and Psychiatry

Taslim,

Shadmani,

Saleem

et al. 2024

Cureus

View full text Add to dashboard Cite

show abstract

“…Synthetic LSD, as well as psilocybin from magic mushrooms, N,N-dimethyltryptamine (DMT), which comes from the herbal beverage ayahuasca, and mescaline from the Peyote cactus, are examples of traditional psychedelic chemicals. They are all agonists of the 5-hydroxytryptamine (HT) 2A receptor, which activates serotonin receptors [5]. According to a list of 20 legal and illegal substances and their negative impacts on users and society, psilocybin and LSD were among the least dangerous.…”

Section: Introductionmentioning

confidence: 99%

Psychedelic Drugs or Hallucinogens: Exploring Their Medicinal Potential

Raj,

Rauniyar,

Sapkale

2023

Cureus

View full text Add to dashboard Cite

Serotonergic hallucinogens also referred to as psychedelics, are psychoactive substances that profoundly alter perception, mood, and cognitive processes. These substances, historically intertwined with religious and cultural rituals, offer profound effects that extend beyond mere hallucinations to profoundly altered states of consciousness. Notable compounds like Lysergic acid diethylamide (LSD) and psilocybin, potent in their action on serotonin receptors, play pivotal roles in influencing brain functions. Despite societal misconceptions that have overshadowed their potential, contemporary research increasingly recognizes their therapeutic value. These substances have shown promise in treating neuropsychiatric disorders such as depression, post-traumatic stress disorder (PTSD), and anxiety, leveraging their influence on neuroplasticity. Furthermore, they exhibit therapeutic potential across various conditions, challenging conventional treatment methodologies. Compared to substances like alcohol, traditional psychedelics like LSD and psilocybin emerge as relatively safer substances. The modern revival of scientific interest in psychedelics necessitates a renewed perspective, viewing them not just as recreational entities but as potent therapeutic tools. Harnessing their actual value mandates rigorous scientific investigations and a receptive societal discourse. A re-evaluation of their classification following international criteria is necessary in light of this increasing understanding. Hallucinogens or psychedelic drugs, if used correctly, can potentially be potential treatments for mental illness, signalling a paradigm shift from traditional techniques. To dispel myths and use their therapeutic advantages, embracing this potential necessitates thorough scientific investigation together with an open societal discourse.

show abstract

Appropriate Drugs

Eleonorasdotter

2023

Women’s Drug Use in Everyday Life

View full text Add to dashboard Cite

This chapter investigates the interviewees’ perceptions of the legitimacy of their own and others’ drug use. Here, the initial focus is on prescribed drugs and their connections to legality and propriety, but also to sickness and control. The division between medicines and drugs, and thus also their effects and cultural frameworks, is analysed as elusive and as the responsibility of patients to assess for themselves. The interviewees’ approach to drugs is analysed in a particular time and place, contemporary Sweden, where psychiatric medication is common and often prescribed. However, some interviewees resist such medications. For them, the use of illegal drugs, paradoxically in the light of their reputation, represents health and self-control. These women describe the use of illegal drugs in an appropriate way as having to do with personal strengths, but a closer look reveals that these “strengths” are in fact class-based resources.

show abstract

Correction: Ketamine for depression – evidence and proposals for practice

Cited by 3 publications

References 0 publications

Neuropsychiatric Disorders: Bridging the Gap Between Neurology and Psychiatry

Neuropsychiatric Disorders: Bridging the Gap Between Neurology and Psychiatry

Psychedelic Drugs or Hallucinogens: Exploring Their Medicinal Potential

Appropriate Drugs

Contact Info

Product

Resources

About